Moneycontrol

Moneycontrol PRO

you are here: HomeNewsBusinessCompaniesGilead, Roche's suit on expected lines: Natco Pharma

SHOW NAMES

Trending Topics

business

Gilead, Roche's suit on expected lines: Natco Pharma

In an interview with CNBC-TV18, Bhaskar Narayana, Finance Director & CFO, Natco Pharma said," In a patently challenged issue, the innovator is bound to protect his rights and this can be done only through the mechanism of suing.There is nothing extra-ordinary about it."

first published: Mar 16, 2011 04:29 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347